Cereno Scientific CEO on new treatments for rare diseases

BioStock met with Cereno Scientific CEO Sten R. Sörensen at BioEurope. Cereno Scientific develops new treatments for rare diseases with the aim of improving and extending the lives of patients who have a severe lack of adequate treatment options. In this interview, Sten shares insights into the company's current projects, their goals at BioEurope and what the future holds.